BioHorizons has near 10% of the global implant market and it will now be reecommending Remplir with them. That's huge product demand.
A little exert from BioHorizons:
"AlloDerm™ RTM is the most widely accepted and researched acellular dermal matrix for dental soft tissue applications. Grafton DBM is a proven bone graft material with clinical success in multiple forms. In 2004, MinerOss®, a mixture of allograft mineralized cortical and cancellous chips, was added to address a wide range of dental bone grafting applications."
They are now selling Remplir instead of Grafton DBM presumably.
Like Paul, I am excited.
Good job you stayed in on half your holdings Hotdog (very nice day on IMU too!)
Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-61
-
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.005(1.10%) |
Mkt cap ! $96.40M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.5¢ | 45.5¢ | $87.13K | 189.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 271 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 21507 | 1 |
View Market Depth
| Last trade - 15.40pm 04/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |